Assignee
ABEXXA BIOLOGICS INC
US·1 granted patent·10 pending applications·7 citations·filing 2018–2021
Top patents by PatentIndex Score
11 records- 0190US10981997B1Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of useABEXXA BIOLOGICS INC·Filed 2020·Granted Apr 20, 2021·7 cites·13 claims
- 0266US2024026007A1Antibodies targeting a complex comprising non-classical hla-i and neoantigen and their methods of useABEXXA BIOLOGICS INC·Filed 2021·Application pending·0 cites
- 0357US2023303701A1Antibodies targeting a complex comprising non-classical hla-i and neoantigen and their methods of useABEXXA BIOLOGICS INC·Filed 2021·Application pending·0 cites
- 0456US2021147572A1Antibodies and methods of use thereofABEXXA BIOLOGICS INC·Filed 2020·Application pending·0 cites
- 0554US2020325244A1Antibodies and methods of use thereofABEXXA BIOLOGICS INC·Filed 2020·Application pending·0 cites
- 0647US2020291128A1Antibodies and methods of use thereofABEXXA BIOLOGICS INC·Filed 2020·Application pending·0 cites
- 0746US2020291127A1Antibodies and methods of use thereofABEXXA BIOLOGICS INC·Filed 2020·Application pending·0 cites
- 0846US2020291116A1Antibodies and methods of use thereofABEXXA BIOLOGICS INC·Filed 2020·Application pending·0 cites
- 0942US2020399377A1Combination cancer therapy with anti-cancer agents and antibodies targeting a complex comprising non-classical hla-i and neoantigenABEXXA BIOLOGICS INC·Filed 2019·Application pending·0 cites
- 1041US2021253713A1Antibodies targeting a complex comprising non-classical hla-i and neoantigen and their methods of useABEXXA BIOLOGICS INC·Filed 2019·Application pending·0 cites
- 1140US2019071502A1Methods and compositions for targeting a complex comprising non-classical hla-i and neoantigen in cancerABEXXA BIOLOGICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ABEXXA BIOLOGICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →